feed,title,long_url,short_url
Benzinga,Fabry Disease Treatment Showdown: Protalix Bio's Elfabrio Joins the Ranks of Sanofi and Amicus Therapeutics,https://benzinga.com/general/biotech/23/05/32321024/fabry-disease-treatment-showdown-protalix-bios-elfabrio-joins-the-ranks-of-sanofi-and-amicus-ther,https://da.gd/tEEly
Benzinga,BellRing Brands Poised For Growth: Analyst Sees Supply Boost And Volume Gains Fueling 1H24 Performance,https://benzinga.com/analyst-ratings/analyst-color/23/05/32323055/bellring-brands-poised-for-growth-analyst-sees-supply-boost-and-volume-gains-fuelin,https://da.gd/YWeZm
